# Quarterhill Inc.: financial statements, quarterly

QTRHF · OTC · CIK 1518419 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qtrhf.md) · [Financials](/companies/qtrhf/financials.md) · [Filings](/companies/qtrhf/filings.md) · [Insiders](/companies/qtrhf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qtrhf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2009-12-31) | period not labelled (2010-12-31) | FY2011 (2011-12-31) | FY2012 (2012-12-31) | FY2013 (2013-12-31) | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [69.2](/filings/0001193125-12-107331.md) | [82.6](/filings/0001193125-13-097636.md) | [432](/filings/0001193125-14-034735.md) | [175](/filings/0001564590-15-000438.md) | [130](/filings/0001564590-16-012432.md) | [126](/filings/0001564590-17-001361.md) | [93.4](/filings/0000950123-18-002756.md) | [107](/filings/0000950123-19-002522.md) | [81.8](/filings/0000950123-19-002522.md) | [63.9](/filings/0000950123-19-002522.md) |
| Current assets | $m | not reported | [112](/filings/0001193125-12-107331.md) | [438](/filings/0001193125-13-097636.md) | [178](/filings/0001193125-14-034735.md) | [144](/filings/0001564590-15-000438.md) | [130](/filings/0001564590-16-012432.md) | [105](/filings/0001564590-17-001361.md) | [131](/filings/0000950123-18-002756.md) | [118](/filings/0000950123-19-002522.md) | [90.7](/filings/0000950123-19-002522.md) |
| Total assets | $m | not reported | [252](/filings/0001193125-12-107331.md) | [589](/filings/0001193125-13-097636.md) | [331](/filings/0001193125-14-034735.md) | [337](/filings/0001564590-15-000438.md) | [313](/filings/0001564590-16-012432.md) | [293](/filings/0001564590-17-001361.md) | [283](/filings/0000950123-18-002756.md) | [303](/filings/0000950123-19-002522.md) | [237](/filings/0000950123-19-002522.md) |
| Current liabilities | $m | not reported | [11.8](/filings/0001193125-12-107331.md) | [237](/filings/0001193125-13-097636.md) | [25.0](/filings/0001193125-14-034735.md) | [44.5](/filings/0001564590-15-000438.md) | [36.3](/filings/0001564590-16-012432.md) | [31.3](/filings/0001564590-17-001361.md) | [26.0](/filings/0000950123-18-002756.md) | [35.6](/filings/0000950123-19-002522.md) | [26.6](/filings/0000950123-19-002522.md) |
| Total liabilities | $m | not reported | [11.8](/filings/0001193125-12-107331.md) | [258](/filings/0001193125-13-097636.md) | [38.5](/filings/0001193125-14-034735.md) | [84.1](/filings/0001564590-15-000438.md) | [67.4](/filings/0001564590-16-012432.md) | [51.8](/filings/0001564590-17-001361.md) | [38.8](/filings/0000950123-18-002756.md) | [48.6](/filings/0000950123-19-002522.md) | [32.5](/filings/0000950123-19-002522.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001193125-12-107331.md) | [5.2](/filings/0001193125-13-097636.md) | [2.7](/filings/0001193125-14-034735.md) | [32.6](/filings/0001564590-15-000438.md) | [27.5](/filings/0001564590-16-012432.md) | [19.9](/filings/0001564590-17-001361.md) | [12.8](/filings/0001564590-17-001361.md) | not reported | not reported |
| Current portion of debt | $m | not reported | [0.0](/filings/0001193125-12-107331.md) | [2.5](/filings/0001193125-13-097636.md) | [2.5](/filings/0001193125-14-034735.md) | [19.5](/filings/0001564590-15-000438.md) | [17.4](/filings/0001564590-16-012432.md) | [8.1](/filings/0001564590-17-001361.md) | [10.4](/filings/0001564590-17-001361.md) | [0.1](/filings/0000950123-19-002522.md) | [0.3](/filings/0000950123-19-002522.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [3.6](/filings/0000950123-19-002522.md) | [2.6](/filings/0000950123-19-002522.md) |
| Shareholders' equity | $m | [229](/filings/0001193125-12-107331.md) | [240](/filings/0001193125-13-097636.md) | [331](/filings/0001193125-14-034735.md) | [292](/filings/0001564590-15-000438.md) | [253](/filings/0001564590-16-012432.md) | [246](/filings/0001564590-17-001361.md) | [241](/filings/0000950123-18-002756.md) | [244](/filings/0000950123-19-002522.md) | [255](/filings/0000950123-19-002522.md) | [205](/filings/0000950123-19-002522.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 118,817,466 at 2018-12-31, from the cover of the [40-F filed 2019-02-28](/filings/0000950123-19-002522.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.